Products of Roche Products Limited.

Rocephin 1G Powder for injection I.M.** Powder for injection
Ceftriaxone (Ceftriaxone Sodium)
1 g
NRN: 04-7302
Actemra 162 mg** Solution for injection
Tocilizumab
162 mg/0.9 mL
NRN: A6-100070
Actemra 200 mg** Concentrate for solution for infusion
Tocilizumab
200 mg/10mL
NRN: A6-100067
Actemra 400 mg** Concentrate for solution for infusion
Tocilizumab
400 mg/20 mL
NRN: A6-100066
Kadcyla Powder for Concentrate for Solution for Infusion 160 mg** Powder for concentrate for solution for infusion
Trastuzumab emtansine
160 mg/8 mL
NRN: A6-100105
Kadcyla Powder for Concentrate for Solution for Infusion 100 mg** Powder for concentrate for solution for infusion
Trastuzumab emtansine
100 mg/5 mL
NRN: A6-0506
MabThera 1400 mg Solution for Subcutaneous Injection** Solution for injection
Rituximab hyaluronidase (SC formulation)
1400 mg/11.7 mL
NRN: A6-0505
Ocrevus** Concentrate for solution for infusion
Ocrelizumab
300 mg/10 mL
NRN: A6-100051
Vabysmo** Solution for injection
Faricimab
6 mg/0.05 mL (120 mg/mL)
NRN: A6-100124
Actemra 80 mg** Concentrate for solution for infusion
Tocilizumab
80 mg/4 mL
NRN: A6-100068
Avastin 100 mg** Concentrate for solution for infusion
Bevacizumab
100 mg/4 mL
NRN: A6-0123
Hemlibra 150 mg** Solution for injection
Emicizumab
150 mg/1 mL
NRN: A6-100134
Hemlibra 30 mg** Solution for injection
Emicizumab
30 mg/1 mL
NRN: A6-100132
Phesgo 600 mg/600 mg/10 mL** Solution for injection
Pertuzumab; Trastuzumab
600 mg/10 mL; 600 mg/10 mL
NRN: A6-100047
Hemlibra 60 mg** Solution for injection
Emicizumab
60 mg/ 0.4mL
NRN: A6-100133
Enspryng Solution for Injection** Solution for injection
Satralizumab
120 mg/1 mL
NRN: A6-100128
Mircera 50 mcg** Solution for injection
Methoxy polyethylene glycol-epoetin beta
50 mcg/0.3 mL
NRN: A6-0121
Mircera 75 mcg** Solution for injection
Methoxy polyethylene glycol-epoetin beta
75 mcg/0.3 mL
NRN: A6-0106
Phesgo 1200 mg/600 mg/15 mL** Solution for injection
Pertuzumab; Trastuzumab
1200 mg/15 mL; 600 mg/15 mL
NRN: A6-100063
Herceptin Solution for Injection (for Subcutaneous Use)** Solution for injection
Trastuzumab hyaluronidase (SC formulation)
600 mg/5 mL
NRN: A6-0481